TR200909786A1 - Sefiksim içeren efervesan tablet ve granül formülasyonu. - Google Patents

Sefiksim içeren efervesan tablet ve granül formülasyonu.

Info

Publication number
TR200909786A1
TR200909786A1 TR2009/09786A TR200909786A TR200909786A1 TR 200909786 A1 TR200909786 A1 TR 200909786A1 TR 2009/09786 A TR2009/09786 A TR 2009/09786A TR 200909786 A TR200909786 A TR 200909786A TR 200909786 A1 TR200909786 A1 TR 200909786A1
Authority
TR
Turkey
Prior art keywords
formulation containing
effervescent tablet
granule formulation
cefixime
containing cefixime
Prior art date
Application number
TR2009/09786A
Other languages
English (en)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/09786A priority Critical patent/TR200909786A1/tr
Priority to TR2010/03856A priority patent/TR201003856A1/tr
Priority to PCT/TR2010/000241 priority patent/WO2011078821A1/en
Priority to EP10795486A priority patent/EP2515849A1/en
Priority to PCT/TR2010/000258 priority patent/WO2011078828A1/en
Priority to PCT/TR2010/000262 priority patent/WO2011078832A1/en
Priority to EP10805547A priority patent/EP2515858A1/en
Publication of TR200909786A1 publication Critical patent/TR200909786A1/tr
Priority to US13/532,120 priority patent/US8614315B2/en
Priority to US14/089,355 priority patent/US20140079647A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Mevcut buluş, sefiksim içeren tablet formlarına ilişkindir. Söz konusu tablet formları efervesan formda olmalarıyla karakterizedir.
TR2009/09786A 2009-12-25 2009-12-25 Sefiksim içeren efervesan tablet ve granül formülasyonu. TR200909786A1 (tr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
TR2009/09786A TR200909786A1 (tr) 2009-12-25 2009-12-25 Sefiksim içeren efervesan tablet ve granül formülasyonu.
TR2010/03856A TR201003856A1 (tr) 2009-12-25 2010-05-14 Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon.
PCT/TR2010/000241 WO2011078821A1 (en) 2009-12-25 2010-12-03 Effervescent tablet and granule formulation comprising cefixime
EP10795486A EP2515849A1 (en) 2009-12-25 2010-12-03 Effervescent tablet and granule formulation comprising cefixime
PCT/TR2010/000258 WO2011078828A1 (en) 2009-12-25 2010-12-24 Pharmaceutical composition with high purity
PCT/TR2010/000262 WO2011078832A1 (en) 2009-12-25 2010-12-24 Effervescent formulations comprising cefixime
EP10805547A EP2515858A1 (en) 2009-12-25 2010-12-24 Pharmaceutical composition with high purity
US13/532,120 US8614315B2 (en) 2009-12-25 2012-06-25 Cefdinir and cefixime formulations and uses thereof
US14/089,355 US20140079647A1 (en) 2009-12-25 2013-11-25 Cefdinir and cefixime formulations and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/09786A TR200909786A1 (tr) 2009-12-25 2009-12-25 Sefiksim içeren efervesan tablet ve granül formülasyonu.

Publications (1)

Publication Number Publication Date
TR200909786A1 true TR200909786A1 (tr) 2011-07-21

Family

ID=43532584

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2009/09786A TR200909786A1 (tr) 2009-12-25 2009-12-25 Sefiksim içeren efervesan tablet ve granül formülasyonu.
TR2010/03856A TR201003856A1 (tr) 2009-12-25 2010-05-14 Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2010/03856A TR201003856A1 (tr) 2009-12-25 2010-05-14 Aktif ajan olarak sefiksim içeren suda çözünebilir formülasyon.

Country Status (3)

Country Link
EP (1) EP2515849A1 (tr)
TR (2) TR200909786A1 (tr)
WO (2) WO2011078821A1 (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8962041B2 (en) 2013-02-12 2015-02-24 Johnson & Johnson Consumer Companies, Inc. Methods and compositions for enhancing hair quality using blackberry extract
CN103494821B (zh) * 2013-10-01 2018-09-25 迪沙药业集团有限公司 一种头孢克肟组合物
CN104366648A (zh) * 2014-10-21 2015-02-25 宣城柏维力生物工程有限公司 甜橙vc泡腾片
CN111544412B (zh) * 2020-04-17 2022-06-24 广州白云山医药集团股份有限公司白云山制药总厂 头孢克肟组合物及其制备方法
CN113440530B (zh) * 2021-07-08 2023-08-08 广州白云山医药集团股份有限公司白云山制药总厂 一种头孢克肟药物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409214A (en) 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
DE3887179T2 (de) 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
WO1997031639A1 (fr) 1996-02-29 1997-09-04 Fujisawa Pharmaceutical Co., Ltd. COMPRIMES CONTENANT UN ANTIBIOTIQUE AU β-LACTAME ET PROCEDE POUR LEUR PRODUCTION
CN100417383C (zh) * 2006-03-07 2008-09-10 中国药科大学 一种含有头孢克肟的泡腾片及制法
CN101606913B (zh) * 2009-07-16 2012-12-19 广州白云山制药股份有限公司广州白云山制药总厂 头孢克肟分散片及其制备方法

Also Published As

Publication number Publication date
WO2011078832A1 (en) 2011-06-30
WO2011078821A1 (en) 2011-06-30
TR201003856A1 (tr) 2011-08-22
EP2515849A1 (en) 2012-10-31

Similar Documents

Publication Publication Date Title
CA145237S (en) Combined cover and saucer
WO2011093824A3 (en) Effervescent formulations comprising cefaclor
CA144920S (en) Bottle
DK2986304T3 (da) Farmaceutisk sammensætning, fremgangsmåder til behandling og anvendelser deraf.
TW201711676A (en) Ferric citrate dosage forms
DK3175711T3 (da) Parasitiske sammensætninger indeholdende multiple aktivstoffer, fremgangsmåder og anvendelser deraf
CA121621S (en) Bottle
GB201106750D0 (en) Novel compounds
CA144229S (en) Drinking flask
EP2569330A4 (en) CHLOROTOXINE VARIANTS, CONJUGATES, AND METHODS OF USE THEREOF
CA143991S (en) Dual function wine device
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
CA146678S (en) Fragrance disk
CA147873S (en) Teapot
MY161601A (en) Films and compositions comprising the same
CA143665S (en) Boot
CA143664S (en) Boot
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
UA112760C2 (uk) Теобромін у комбінації з гвайфенезином для лікування кашлю
TR200909786A1 (tr) Sefiksim içeren efervesan tablet ve granül formülasyonu.
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
ATE483720T1 (de) Verbindungen enthaltend organofluorochlorophosphatanionen
MY175703A (en) Tablets with improved acceptance and good storage stability
CA121620S (en) Bottle
IT1399492B1 (it) Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina.